Stay updated on ABSK-021 Safety in Solid Tumor Patients Clinical Trial

Sign up to get notified when there's something new on the ABSK-021 Safety in Solid Tumor Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABSK-021 Safety in Solid Tumor Patients Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    No significant updates to core study information are visible between the two screenshots.
    Difference
    0.3%
    Check dated 2025-11-03T01:22:20.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    Core content updated with a government-operational notice and a new version tag (v3.2.0); a specific GRDC resource entry was removed (Tenosynovial giant cell tumor, diffuse type) and the version history shows a backward-incompatible removal from v3.1.0 to v3.2.0.
    Difference
    4%
    Check dated 2025-10-05T10:11:53.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Update includes a new revision version (v3.1.0) and new contact details; previous revision (v3.0.2) is removed. No evidence of changes to core content beyond the metadata and contact info.
    Difference
    0.1%
    Check dated 2025-09-28T03:12:40.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' element.
    Difference
    0.2%
    Check dated 2025-09-13T16:58:47.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.2%
    Check dated 2025-09-06T14:31:55.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The web page has updated its facility name and location details, specifically adding references to Beijing and Shanghai, while removing previous location terms and certain resources related to genetic diseases.
    Difference
    3%
    Check dated 2025-08-30T11:16:04.000Z thumbnail image

Stay in the know with updates to ABSK-021 Safety in Solid Tumor Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABSK-021 Safety in Solid Tumor Patients Clinical Trial page.